US OptionsDetailed Quotes

MRSN250117P1500

Watchlist

0.25
0.000.00%

15min DelayTrading Dec 26 10:19 ET

0.00High0.00Low

Mersana Therapeutics Stock Discussion

Trytosaveabit

Sep 30 05:11

Watching for this!

$Mersana Therapeutics (MRSN.US)$ Expected to announce initial XMT-1660 clinical data and initiate expansion in the second half of 2024

Moomoo AI

Feb 22 13:53

Despite a recent share price hike, Mersana Therapeutics' P/S ratio lags behind others due to forecasted revenue decline. Without major changes, a drastic stock price rise is unlikely.

Mersana Therapeutics, Inc.'s (NASDAQ:MRSN) Shares Bounce 31% But Its Business Still Trails The Industry

Moomoo AI

Dec 20, 2023 06:43

Mersana Therapeutics forecasted future revenue decline contributes to lower P/S ratio, limiting strong rise potential in share prices. The market expects performance drop, keeping P/S suppressed. For P/S to avoid further fall, top-line growth needs improvement.